Effect of probiotics on colorectal cancer in clinical trials
Phase 1
- Conditions
- - Colorectal cancer is the third most prevalent cause of death among the different types of cancer worldwide- imbalance of microorganisms in gut causes colorectal cancer- Probiotic strains can help to balance of microorganisms in gutprobiotics, colorectal cancer, butyrate, anti-inflammation, stimulating immune
- Registration Number
- TCTR20220408001
- Lead Sponsor
- Health Systems Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. have been diagnosed as having colorectal cancer stage 2-3
2. 30 subjects were included
Exclusion Criteria
1. any other systemic diseases e.g. diabetes, myocardial infarction kidney diseases
2. immuno-compromised host
3. allergy for cow milk
4. having a habit for regular taking fermented food
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduceing of number of pathogens in gut at 6 months after intervention number of pathogens / Anova
- Secondary Outcome Measures
Name Time Method reducing of pro-inflammatory cytokines in serum at 6 months after intervention pro-inflammatory cytokines / ANOVA